What about all the Cannabis Co that trade OTC...so what you're saying if we sign license deal in HIV or prostate with BP...or get pivotal in mono OR get financing outside of Paulson that's non dilutive to finance BLA and pay for 2019 expenses.... AND have great phase 2 results you think we would still struggle to get above $1...serious question I'm asking